-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathhistory.html
877 lines (861 loc) · 44 KB
/
history.html
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<link rel="preconnect" href="https://cdnjs.cloudflare.com">
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link rel="preload" href="https://fonts.googleapis.com/css2?family=Outfit:wght@400;500;700;900&display=swap"
as="style" onload="this.onload=null;this.rel='stylesheet'">
<noscript>
<link href="https://fonts.googleapis.com/css2?family=Outfit:wght@400;500;700;900&display=swap" rel="stylesheet">
</noscript>
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/[email protected]/dist/css/bootstrap.min.css"
integrity="sha384-xOolHFLEh07PJGoPkLv1IbcEPTNtaed2xpHsD9ESMhqIYd0nLMwNLD69Npy4HI+N" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.2/css/all.min.css">
<link rel="stylesheet" href="/assets/css/main.css">
<link rel="stylesheet" href="/assets/css/history.css">
<link rel="stylesheet" href="/assets/css/chatbot.css">
<link rel="preload" href="/assets/images/covid.jpg" as="image">
<link rel="icon" href="/assets/logo/CoviUlt.jpg" type="image/jpg">
<title>History | CoviUlt</title>
</head>
<body>
<!-- navbar start -->
<nav class="header shadow-lg p-3 bg-white rounded">
<div class="logo"><a href="/" class="logo-link">CoviUlt</a></div>
<div class="header-links">
<a class="underline" href="/">Home</a>
<a class="underline" href="/impact.html">Impact</a>
<a class="underline" href="/vaccine.html">Vaccine</a>
<a class="underline" href="/history.html">History</a>
<a class="underline" href="/know-more.html">Know More</a>
</div>
</nav>
<nav class="mobile-menu shadow-lg p-3 bg-white rounded sticky-top w-100">
<div class="container-nav">
<div class="logo px-3"><a href="/" class="logo-link">CoviUlt</a></div>
<input type="checkbox" class="toggle">
<div class="hamburger"><span></span></div>
<div class="menu">
<ul class="menu-links">
<li><a class="underline" href="/">Home</a></li>
<li><a class="underline" href="/impact.html">Impact</a></li>
<li><a class="underline" href="/vaccine.html">Vaccine</a></li>
<li><a class="underline" href="/history.html">History</a></li>
<li><a class="underline" href="/know-more.html">Know More</a></li>
</ul>
</div>
</div>
</nav>
<!-- navbar ends -->
<section id="history-timeline">
<div class="timeline">
<div class="timeline-container left">
<div class="date">31 Dec 2019</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
Wuhan Municipal Health Commission, China, reported a cluster of cases of pneumonia in Wuhan,
Hubei Province. A novel coronavirus was eventually identified.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">1 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO had set up the IMST (Incident Management Support Team) across the three levels of the
organization: headquarters, regional headquarters and country level, putting the organization on
an emergency footing for dealing with the outbreak.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">4 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO reported on social media that there was a cluster of pneumonia cases – with no deaths – in
Wuhan, Hubei province
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">5 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO published our first Disease Outbreak News on the new virus. This is a flagship technical
publication to the scientific and public health community as well as global media. It contained
a risk assessment and advice, and reported on what China had told the organization about the
status of patients and the public health response on the cluster of pneumonia cases in Wuhan.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">10 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued a comprehensive package of technical guidance online with advice to all countries on
how to detect, test and manage potential cases, based on what was known about the virus at the
time. This guidance was shared with WHO's regional emergency directors to share with WHO
representatives in countries.
<br>
Based on experience with SARS and MERS and known modes of transmission of respiratory viruses,
infection and prevention control guidance were published to protect health workers recommending
droplet and contact precautions when caring for patients, and airborne precautions for aerosol
generating procedures conducted by health workers.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">12 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
China publicly shared the genetic sequence of COVID-19.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">13 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
Officials confirm a case of COVID-19 in Thailand, the first recorded case outside of China.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">14 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO's technical lead for the response noted in a press briefing there may have been limited
human-to-human transmission of the coronavirus (in the 41 confirmed cases), mainly through
family members, and that there was a risk of a possible wider outbreak. The lead also said that
human-to-human transmission would not be surprising given our experience with SARS, MERS and
other respiratory pathogens.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">21 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO experts from its China and Western Pacific regional offices conducted a brief field visit to
Wuhan.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">22 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO mission to China issued a statement saying that there was evidence of human-to-human
transmission in Wuhan but more investigation was needed to understand the full extent of
transmission.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">23 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
The WHO Director- General convened an Emergency Committee (EC) under the International Health
Regulations (IHR 2005) to assess whether the outbreak constituted a public health emergency of
international concern. The independent members from around the world could not reach a consensus
based on the evidence available at the time. They asked to be reconvened within 10 days after
receiving more information.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">28 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
A senior WHO delegation led by the Director-General travelled to Beijing to meet China’s
leadership, learn more about China’s response, and to offer any technical assistance. <br>
While in Beijing, Dr. Tedros agreed with Chinese government leaders that an international team
of leading scientists would travel to China on a mission to better understand the context, the
overall response, and exchange information and experience.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">30 Jan 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
The WHO Director-General reconvened the Emergency Committee (EC). This was earlier than the
10-day period and only two days after the first reports of limited human-to-human transmission
were reported outside China. This time, the EC reached consensus and advised the
Director-General that the outbreak constituted a Public Health Emergency of International
Concern (PHEIC). The Director-General accepted the recommendation and declared the novel
coronavirus outbreak (2019-nCoV) a PHEIC. This is the 6th time WHO has declared a PHEIC since
the International Health Regulations (IHR) came into force in 2005. <br>
WHO’s situation report for 30 January reported 7818 total confirmed cases worldwide, with the
majority of these in China, and 82 cases reported in 18 countries outside China. WHO gave a risk
assessment of very high for China, and high at the global level.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">3 Feb 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO releases the international community's Strategic Preparedness and Response Plan to help
protect states with weaker health systems.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">11 Feb 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO convened a Research and Innovation Forum on COVID-19, attended by more than 400 experts and
funders from around the world, which included presentations by George Gao, Director General of
China CDC, and Zunyou Wu, China CDC's chief epidemiologist.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">16 Feb 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
The WHO-China Joint mission, which included experts from Canada, Germany, Japan, Nigeria,
Republic of Korea, Russia, Singapore and the US (CDC, NIH) spent time in Beijing and also
travelled to Wuhan and two other cities. They spoke with health officials, scientists and health
workers in health facilities (maintaining physical distancing). The report of the joint mission
can be found here:
https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">11 Mar 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
Deeply concerned both by the alarming levels of spread and severity, and by the alarming levels
of inaction, WHO made the assessment that COVID-19 can be characterized as a pandemic.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">13 Mar 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
COVID-19 Solidarity Response Fund launched to receive donations from private individuals,
corporations and institutions.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">18 Mar 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO and partners launch the Solidarity Trial, an international clinical trial that aims to
generate robust data from around the world to find the most effective treatments for COVID-19.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">20 Mar 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO Health Alert, which offers instant and accurate information about COVID-19, launched on
WhatsApp. It is available in multiple languages with users around the world.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">31 Mar 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued a Medical Product Alert warning consumers, healthcare professionals, and health
authorities against a growing number of falsified medical products that claim to prevent,
detect, treat or cure COVID-19.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">4 Apr 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO reported that over 1 million cases of COVID-19 had been confirmed worldwide, a more than
tenfold increase in less than a month.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">13 Apr 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO published a statement by 130 scientists, funders and manufacturers from around the world, in
which they committed to working with WHO to speed the development of a vaccine against COVID-19.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">27 May 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO published interim guidance on the clinical management of COVID-19.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">5 Jun 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO published updated guidance on the use of masks for the control of COVID-19, which provided
updated advice on who should wear a mask, when it should be worn and what it should be made of.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">13 Jun 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO reported that Chinese authorities had provided information on a cluster of COVID-19 cases in
Beijing, People’s Republic of China.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">16 Jun 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO welcomed initial clinical trial results from the UK that showed dexamethasone, a
corticosteroid, could be lifesaving for patients critically ill with COVID-19. The news built
off the Global Research and Innovation Forum, which took place in Geneva in mid-February
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">17 Jun 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO announced that the hydroxychloroquine arm of the Solidarity Trial to find an effective
COVID-19 treatment was being stopped.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">4 Jul 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO announced that the hydroxychloroquine and lopinavir/ritonavir arms of the Solidarity trial
to find an effective COVID-19 treatment were being discontinued.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">6 Jul 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO shared survey findings, showing that seventy-three countries have warned that they are at
risk of stock-outs of antiretroviral (ARV) medicines as a result of the COVID-19 pandemic.
Twenty-four countries reported having either a critically low stock of ARVs.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">8 Jul 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
The Director-General participated in a WHO webinar with civil society organizations to discuss
how to engage them in COVID-19 responses at the national and local levels, with a stated plan of
future events on these issues.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">9 Jul 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued an updated Scientific Brief on COVID-19 transmission, providing information on how,
when and in which settings the virus spreads between people. The brief described possible modes
of transmission, including contact, droplet, airborne, fomite,...
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">15 Jul 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
The COVAX Facility, a mechanism designed to guarantee rapid, fair and equitable access to
COVID-19 vaccines worldwide, secured engagement from more than 150 countries, representing over
60% of the world’s...
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">31 Jul 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
The Director-General convened the IHR Emergency Committee on COVID-19 (EC) for a fourth time.
The EC met on 31 July and issued its statement on 1 August.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">7 Aug 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO published updated guidance on public health surveillance for COVID-19, which includes
revised suspected and probable case definitions that integrate new knowledge about the clinical
spectrum of COVID-19 and its transmission.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">11 Sep 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO published interim guidance, highlighting the value of antigen based rapid diagnostic tests
for the SARS-CoV-2 virus, in areas where community transmission is widespread and where nucleic
acid amplification-based diagnostic testing is unavailable.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">17 Sep 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
With health workers exposed to unprecedented risk from COVID-19, WHO released a Charter on World
Patient Safety Day, calling for steps to protect health workers from violence; to improve their
mental health
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">22 Sep 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued the first Emergency Use Listing for a quality antigen based rapid diagnostic test for
detecting the SARS-CoV-2 virus, which causes COVID-19.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">15 Oct 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO announced conclusive evidence on the effectiveness of repurposed drugs for COVID-19. Interim
results from the Solidarity Trial indicated that remdesivir, hydroxychloroquine,
lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day
mortality or the in-hospital course of COVID-19 among hospitalized patients.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">18 Nov 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
The WHO Academy launched its first augmented reality course for
health workers on the proper use of COVID-19 personal protective equipment.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">3 Dec 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued a second Disease Outbreak News report on a SARS-CoV-2 mink-associated variant strain,
reported by Danish authorities.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">14 Dec 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
United Kingdom authorities reported a SARS-CoV-2 variant to WHO. The United Kingdom referred to
the variant as SARS-CoV-2 VOC 202012/01 (Variant of Concern, year 2020, month 12,
variant 01).
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">18 Dec 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
COVAX announced further deals, adding to existing agreements, which collectively gave it access
to nearly two billion doses of several promising COVID-19 vaccine candidates, which should
enable all participating countries to have access to doses in the first half of 2021.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">21 Dec 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued a Disease Outbreak News report on the SARS-CoV-2 VUI 202012/01 variant reported to
WHO by UK authorities.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">31 Dec 2020</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued its first emergency use validation for a COVID-19 vaccine and emphasized the need for
equitable global access.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">22 Jan 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all
countries, announced the signing of an advance purchase agreement for up to 40 million doses of
the Pfizer-BioNTech vaccine. COVAX also confirmed it would exercise its option – via an existing
agreement with the Serum Institute of India (SII) – to receive its first 100 million doses of
the AstraZeneca/Oxford University-developed vaccine manufactured by SII.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">25 Jan 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued interim recommendations for the use of the Moderna mRNA-1273 vaccine against
COVID-19, developed on the basis of the advice issued by the Strategic Advisory Group of Experts
(SAGE) on Immunization at its extraordinary meeting on 21 January 2021.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">29 Jan 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO published its new Essential Diagnostics List, which includes WHO-recommended COVID-19 tests
(PCR and Antigen).
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">8 Feb 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
COVAX issued a statement on new variants of SARS-CoV-2, underscoring the importance of
determining the AstraZeneca/Oxford vaccine's effectiveness when it comes to preventing more
severe illness caused by the B.1.351 variant, through additional studies.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">15 Feb 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the
green light for these vaccines to be rolled out globally through COVAX. The vaccines are
produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">24 Feb 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
COVAX’s global rollout began, as Ghana became the first country outside India to receive
COVID-19 vaccine doses shipped via COVAX.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">7 Apr 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
COVAX delivered life-saving vaccines to over 100 economies, 42 days after its first
international delivery. As of 7 Apr 2021, COVAX had delivered more than 38 million doses across
six continents.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">30 Apr 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO listed the Moderna COVID-19 vaccine (mRNA 1273) for emergency use, allowing countries to
expedite their own regulatory approvals and enabling the vaccine to be rolled out through COVAX.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">12 Aug 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued a statement on advancing the next series of studies to find the origins of
SARS-CoV-2.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">3 Nov 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued its eighth emergency use listing for a COVID-19 vaccine, for COVAXIN®, developed by
Bharat Biotech. WHO interim recommendations for the use of COVAXIN® were also issued, having
been developed on the basis of advice issued by the Strategic Advisory Group of Experts on
Immunization (SAGE).
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">17 Dec 2021</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO issued its ninth emergency use listing for a COVID-19 vaccine, for CovovaxTM, produced by
the Serum Institute of India under licence from Novavax. Part of the COVAX facility portfolio,
the vaccine gave a much-needed boost to ongoing efforts to vaccinate more people in lower-income
countries.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">11 Jan 2022</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
The Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) issued an interim
statement about implications of the Omicron variant for current COVID-19 vaccines and the
group's perspective on vaccine options for the future.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">14 Jan 2022</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO recommended two new drugs to treat COVID-19.
WHO strongly recommended baricitinib for patients with severe or critical COVID-19.
WHO also conditionally recommended the use of a monoclonal antibody drug, sotrovimab, for
treating mild or moderate COVID-19 in patients who are at high risk of hospitalization.
</p>
</div>
</div>
<div class="timeline-container left">
<div class="date">15 Jan 2022</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
COVAX delivered its billionth COVID-19 vaccine dose, with a shipment of 1.1 million doses to
Rwanda.
</p>
</div>
</div>
<div class="timeline-container right">
<div class="date">11 Feb 2022</div>
<i class="icon fas fa-virus"></i>
<div class="content">
<p>
WHO prequalified its first monoclonal antibody – tocilizumab – to treat COVID-19.
</p>
</div>
</div>
</div>
</section>
<!-- footer start -->
<footer class="text-center text-lg-start bg-light text-muted">
<section class="d-flex justify-content-center justify-content-lg-between p-4 border-bottom">
<div class=" d-none d-lg-block">
<span>Get connected with us on social networks:</span>
</div>
<div>
<a href="#" class="m-4 text-reset">
<i class="fab fa-facebook-f"></i>
</a>
<a href="#" class="m-4 text-reset">
<i class="fab fa-twitter"></i>
</a>
<a href="#" class="m-4 text-reset">
<i class="fab fa-instagram"></i>
</a>
<a href="#" class="m-4 text-reset">
<i class="fab fa-linkedin"></i>
</a>
</div>
</section>
<section class="">
<div class="container text-center text-md-start mt-5">
<div class="row mt-3">
<div class="col-md-3 col-lg-4 col-xl-3 mx-auto mb-4">
<h6 class="text-uppercase fw-bold mb-4">
CoviUlt
</h6>
<p>
The Ultimate Knowledgebase for information regarding COVID-19 Pandemic
</p>
</div>
<div class="col-md-2 col-lg-2 col-xl-2 mx-auto mb-4">
<h6 class="text-uppercase fw-bold mb-4">
Navigation
</h6>
<p>
<a href="/" class="text-reset">Home</a>
</p>
<p>
<a href="/impact.html" class="text-reset">Impact</a>
</p>
<p>
<a href="/vaccine.html" class="text-reset">Vaccine</a>
</p>
<p>
<a class="text-reset" href="/history.html">History</a>
</p>
<p>
<a href="/know-more.html" class="text-reset">Know More</a>
</p>
</div>
<div class="col-md-3 col-lg-2 col-xl-2 mx-auto mb-4">
<h6 class="text-uppercase fw-bold mb-4">
Useful links
</h6>
<p>
<a href="/know-more/faq-covid.html" class="text-reset">FAQ COVID-19</a>
</p>
<p>
<a href="/know-more/faq-vaccine.html" class="text-reset">FAQ Vaccine</a>
</p>
<p>
<a href="/know-more/faq-vaccine.html" class="text-reset">FAQ CoviShield</a>
</p>
</div>
<div class="col-md-4 col-lg-3 col-xl-3 mx-auto mb-md-0 mb-4">
<h6 class="text-uppercase fw-bold mb-4">
Contact US
</h6>
<p><i class="fas fa-home me-3"></i> Tripura, India</p>
<p>
<i class="fas fa-envelope me-3"></i>
<a href="mailto:[email protected]">[email protected]</a>
</p>
<p><i class="fas fa-phone me-3 text-decoration-none"></i> <a href="tel:+0000 000 000">+0000 000
000</a></p>
</div>
</div>
</div>
</section>
<div class="text-center p-4" style="background-color: rgba(0, 0, 0, 0.05);">
© 2022 Copyright:
<a class="text-reset fw-bold" href="https://coviult.codewithbishal.com">coviult.codewithbishal.com</a>
</div>
</footer>
<!-- floating btn -->
<button class="float button row justify-content-center align-items-center" id="readAloud" title="Read Aloud">
<i class="fa fa-volume-up my-float"></i> Read
</button>
<button class="float button row justify-content-center align-items-center" id="muteSpeech" title="Turn off Read Aloud" style="display: none;">
<i class="fa fa-volume-mute my-float"></i> Mute
</button>
<div class="chatBot">
<input type="checkbox" id="click" class="click" />
<label for="click" id="openChat" style="position: fixed;">
<i class="far fa-comment-dots"></i>
</label>
<div class="wrapper" style="position: fixed;">
<div class="chat-box-header d-flex justify-content-between align-items-center">
<div class="icon_header p-2 ml-2 rounded-circle">
<img class="img-fluid" src="/assets/images/chatbot.png" />
</div>
<div class="name">CoviBot</div>
<span class="chat-box-toggle"><label id="showFAB" for="click">
<i class="fas fa-times"></i>
</label></span>
</div>
<div class="form">
<div class="bot-inbox align-items-center inbox">
<div class="icon">
<img class="bot-dp img-fluid" src="/assets/images/chatbot.png" />
</div>
<div class="msg-header">
<div>Hello I'm CoviBot, I'm here to answer your Questions regarding Covid-19</div>
</div>
</div><br>
<div class="bot-inbox align-items-center inbox">
<div class="icon">
<img class="bot-dp img-fluid" src="/assets/images/chatbot.png" />
</div>
<div class="msg-header">
<div>If you are experiencing a life-threatening emergency, please call <a
href="tel:1075">1075</a> immediately <br> This system does not replace the judgement of
healthcare professionals or the performance of any clinical assessment.</div>
</div>
</div>
</div>
<div class="typing-field">
<div class="input-data">
<input id="data" type="text" placeholder="Type something here.." required />
<button id="send-btn">Send</button>
</div>
</div>
</div>
</div>
<!-- floating btn -->
<!-- footer ends -->
<script src="https://cdn.jsdelivr.net/npm/[email protected]/dist/jquery.slim.min.js"
integrity="sha384-DfXdz2htPH0lsSSs5nCTpuj/zy4C+OGpamoFVy38MVBnE+IbbVYUew+OrCXaRkfj"
crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/[email protected]/dist/js/bootstrap.bundle.min.js"
integrity="sha384-Fy6S3B9q64WdZWQUiU+q4/2Lc9npb8tCaSX9FK7E8HnRr0Jz8D6OP9dO5Vg3Q9ct"
crossorigin="anonymous"></script>
<script src="/assets/js/chatbot.js"></script>
<script src="/assets/js/speech.js"></script>
</body>
</html>